Your Location：
Home >
Browse articles >
Guizhi Fulingwan Alleviate Hepatic Fibrosis by Modulating mtDNA/NLRP3/Caspase-1/GSDMD Signaling Pathway
Guizhi Fulingwan Alleviate Hepatic Fibrosis by Modulating mtDNA/NLRP3/Caspase-1/GSDMD Signaling Pathway
Enhanced Publication- “The mechanism of Guizhi Fuling Pill in anti liver fibrosis has been revealed, which may be related to reducing mitochondrial damage, inhibiting the assembly and activation of inflammasomes, and preventing the release of inflammatory factors. This has opened up new directions for the research of traditional Chinese medicine in anti fibrosis.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 14, Pages: 91-99(2026)
DOI： 10.13422/j.cnki.syfjx.20252001
Revised：2025-08-14 ，
Accepted：02 September 2025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 3 ) Tabs( 5 )
References
Publication Info
Metrics
266
Views
138
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
No data
Related Author
TANG Yu
YANG Xuli
YANG Qiang
WANG Xiaojie
GAO Yongxiang
LI Xueping
HE Wangsheng
ZHU Yanping
Related Institution
Hospital of Chengdu University of Traditional Chinese Medicine
Lezhi County Hospital of Traditional Chinese Medicine
School of Basic Medical Sciences， Chengdu University of Traditional Chinese Medicine
The First Affiliated Hospital of Anhui University of Chinese Medicine
Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine， Institute of Health and Medicine，Hefei Comprehensive National Science Center
Intro
Chat
